• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝病中的髓系细胞:机制与展望。

Myeloid cells in alcoholic liver diseases: Mechanism and prospect.

机构信息

Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China.

出版信息

Front Immunol. 2022 Aug 10;13:971346. doi: 10.3389/fimmu.2022.971346. eCollection 2022.

DOI:10.3389/fimmu.2022.971346
PMID:36032154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9399804/
Abstract

Alcoholic liver disease (ALD) is a leading chronic liver disease in which immune cells play a vital role. Myeloid cells have been extensively studied in ALD, including granulocytes, macrophages, monocytes, and dendritic cells, which are involved in the occurrence and progression of steatosis, inflammation, fibrosis, and eventual cirrhosis. These cells can be popularly targeted and regulated by factors from different sources, including cytokines secreted by other cells, extracellular vesicles, and substances in serum-for example, infiltration of monocytes or neutrophils, activation of Kupffer cells, and polarization of macrophages. These processes can affect and change the function and phenotype of myeloid cells. Here we mainly review the key mediators that affect the infiltration and function of mainly myeloid cells in ALD as well as their regulatory mechanisms on target cells, which may provide novel immunotherapeutic approaches. The single-cell multimodal omics of myeloid cells is also discussed to help transform them into basic research or therapeutic strategy of ALD clinically.

摘要

酒精性肝病(ALD)是一种主要的慢性肝病,其中免疫细胞起着至关重要的作用。髓系细胞在 ALD 中已经得到了广泛的研究,包括粒细胞、巨噬细胞、单核细胞和树突状细胞,它们参与了脂肪变性、炎症、纤维化和最终肝硬化的发生和发展。这些细胞可以通过不同来源的因子进行靶向和调节,包括其他细胞分泌的细胞因子、细胞外囊泡和血清中的物质,例如单核细胞或中性粒细胞的浸润、枯否细胞的激活和巨噬细胞的极化。这些过程可以影响和改变髓系细胞的功能和表型。在这里,我们主要综述了影响 ALD 中主要髓系细胞浸润和功能的关键介质及其对靶细胞的调节机制,这可能为免疫治疗提供新的方法。还讨论了髓系细胞的单细胞多组学,以帮助将其转化为 ALD 的基础研究或治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/9399804/8bf904550818/fimmu-13-971346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/9399804/991317695352/fimmu-13-971346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/9399804/8bf904550818/fimmu-13-971346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/9399804/991317695352/fimmu-13-971346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/9399804/8bf904550818/fimmu-13-971346-g002.jpg

相似文献

1
Myeloid cells in alcoholic liver diseases: Mechanism and prospect.酒精性肝病中的髓系细胞:机制与展望。
Front Immunol. 2022 Aug 10;13:971346. doi: 10.3389/fimmu.2022.971346. eCollection 2022.
2
Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease.靶向髓系细胞:非酒精性和酒精性肝病治疗的新前沿。
Front Immunol. 2019 Mar 27;10:563. doi: 10.3389/fimmu.2019.00563. eCollection 2019.
3
Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.酒精性和非酒精性脂肪性肝炎的进展:固有免疫系统和氧化应激的共同代谢方面。
Drug Metab Pharmacokinet. 2011;26(1):30-46. doi: 10.2133/dmpk.dmpk-10-rv-087. Epub 2010 Dec 7.
4
Macrophages and Alcohol-Related Liver Inflammation.巨噬细胞与酒精性肝炎症
Alcohol Res. 2015;37(2):251-62.
5
Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease.脂肪性肝病中髓系细胞的适应性免疫反应。
Front Immunol. 2018 Oct 18;9:2418. doi: 10.3389/fimmu.2018.02418. eCollection 2018.
6
Alcoholic Liver Disease: Role of Cytokines.酒精性肝病:细胞因子的作用
Biomolecules. 2015 Aug 28;5(3):2023-34. doi: 10.3390/biom5032023.
7
Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.库普弗细胞通过产生肿瘤坏死因子-α触发饮食诱导的小鼠模型中非酒精性脂肪性肝炎的发生。
J Biol Chem. 2012 Nov 23;287(48):40161-72. doi: 10.1074/jbc.M112.417014. Epub 2012 Oct 12.
8
Myeloid Mixed Lineage Kinase 3 Contributes to Chronic Ethanol-Induced Inflammation and Hepatocyte Injury in Mice.髓系混合谱系激酶3促成小鼠慢性乙醇诱导的炎症和肝细胞损伤。
Gene Expr. 2016;17(1):61-77. doi: 10.3727/105221616X691730. Epub 2016 Jun 9.
9
Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.酒精性肝病的分子机制:固有免疫与细胞因子。
Alcohol Clin Exp Res. 2011 May;35(5):787-93. doi: 10.1111/j.1530-0277.2010.01399.x. Epub 2011 Feb 1.
10
Pathogenesis of alcoholic liver disease: role of oxidative metabolism.酒精性肝病的发病机制:氧化代谢的作用。
World J Gastroenterol. 2014 Dec 21;20(47):17756-72. doi: 10.3748/wjg.v20.i47.17756.

引用本文的文献

1
Food plants as adjuvant medicines: a review of protective effects and clinical potential in alcoholic liver disease.作为辅助药物的食用植物:对酒精性肝病保护作用及临床潜力的综述
Front Pharmacol. 2025 May 22;16:1586238. doi: 10.3389/fphar.2025.1586238. eCollection 2025.
2
Role of immune cell interactions in alcohol-associated liver diseases.免疫细胞相互作用在酒精性肝病中的作用。
Liver Res. 2024 Jun 10;8(2):72-82. doi: 10.1016/j.livres.2024.06.002. eCollection 2024 Jun.
3
Circulating myeloid populations have prognostic utility in alcohol-related liver disease.

本文引用的文献

1
Omics and AI advance biomarker discovery for liver disease.组学和人工智能推动了肝脏疾病生物标志物的发现。
Nat Med. 2022 Jun;28(6):1131-1132. doi: 10.1038/s41591-022-01853-9.
2
Macrophage-derived MLKL in alcohol-associated liver disease: Regulation of phagocytosis.酒精相关性肝病中巨噬细胞衍生的 MLKL:吞噬作用的调节。
Hepatology. 2023 Mar 1;77(3):902-919. doi: 10.1002/hep.32612. Epub 2023 Feb 17.
3
The spatiotemporal program of zonal liver regeneration following acute injury.急性损伤后区域性肝再生的时空程序。
循环髓系细胞群体在酒精性肝病中有预后作用。
Front Immunol. 2024 Mar 13;15:1330536. doi: 10.3389/fimmu.2024.1330536. eCollection 2024.
4
Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment.正在参与肝纤维化的治疗靶点和有前途的治疗靶点:肝免疫微环境。
Front Immunol. 2023 Feb 16;14:1131588. doi: 10.3389/fimmu.2023.1131588. eCollection 2023.
Cell Stem Cell. 2022 Jun 2;29(6):973-989.e10. doi: 10.1016/j.stem.2022.04.008.
4
Noninvasive proteomic biomarkers for alcohol-related liver disease.用于酒精性肝病的非侵入性蛋白质组学生物标志物。
Nat Med. 2022 Jun;28(6):1277-1287. doi: 10.1038/s41591-022-01850-y. Epub 2022 Jun 2.
5
Therapeutic advances in alcohol-associated hepatitis.酒精相关性肝炎的治疗进展。
J Hepatol. 2022 Jun;76(6):1279-1290. doi: 10.1016/j.jhep.2022.03.025.
6
Hepatic Protein and Phosphoprotein Signatures of Alcohol-Associated Cirrhosis and Hepatitis.酒精相关性肝硬化和肝炎的肝蛋白和磷酸化蛋白特征。
Am J Pathol. 2022 Jul;192(7):1066-1082. doi: 10.1016/j.ajpath.2022.04.004. Epub 2022 Apr 28.
7
Ethanol promoting the upregulation of C-X-C Motif Chemokine Ligand 1(CXCL1) and C-X-C Motif Chemokine Ligand 6(CXCL6) in models of early alcoholic liver disease.乙醇促进早期酒精性肝病模型中 C-X-C 基序趋化因子配体 1(CXCL1)和 C-X-C 基序趋化因子配体 6(CXCL6)的上调。
Bioengineered. 2022 Mar;13(3):4688-4701. doi: 10.1080/21655979.2022.2030557.
8
Temporal analyses of postnatal liver development and maturation by single-cell transcriptomics.单细胞转录组学分析出生后肝脏发育和成熟的时间过程。
Dev Cell. 2022 Feb 7;57(3):398-414.e5. doi: 10.1016/j.devcel.2022.01.004.
9
Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis.肝巨噬细胞靶向 siRNA 脂质纳米粒治疗非酒精性脂肪性肝炎。
J Control Release. 2022 Mar;343:175-186. doi: 10.1016/j.jconrel.2022.01.038. Epub 2022 Jan 29.
10
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches.空间蛋白质组学揭示了独特且进化上保守的肝巨噬细胞生态位。
Cell. 2022 Jan 20;185(2):379-396.e38. doi: 10.1016/j.cell.2021.12.018. Epub 2022 Jan 11.